IP Litigation Finance vs. Commercial Litigation Finance

IP litigation finance suits patent holders, trademark owners, or trade secret claimants pursuing infringement or misappropriation claims where validity challenges, technical complexity, and specialized damages methodologies dominate the risk profile in ways a generalist commercial funder's framework does not fully address. It is especially relevant to operating companies and universities holding a patent portfolio they intend to enforce rather than simply license.

Commercial litigation finance suits businesses and firms pursuing a broader range of claims — breach of contract, fraud, business torts — where the underwriting focuses on liability, damages, and collectability without the patent-specific validity and technical risk layers that define IP matters. This is the more established and standardized segment of the litigation finance market by deployed capital.

The funder evaluates the patent or trademark's validity and enforceability, the strength of the infringement or misappropriation theory, and — for patents — the risk that a challenge such as inter partes review invalidates the asserted claims before the litigation ever reaches a damages determination, alongside conventional liability and damages analysis. This typically requires engaging a technical expert with subject-matter expertise in the specific patented technology at issue.

The funder evaluates the claim through the standard commercial framework — liability strength, damages methodology, collectability of any judgment, and the litigation team's capability — without a parallel validity-challenge risk layer specific to intellectual property. This narrower diligence scope generally allows commercial claims to be underwritten somewhat faster than a comparable IP matter.

Pricing accounts for the added risk that a patent could be invalidated entirely regardless of infringement, a binary risk that can eliminate a claim's value outright in a way most commercial disputes do not face, which generally supports a more conservative advance relative to expected damages than a comparable non-IP commercial claim. Claims already past an inter partes review challenge without their claims narrowed carry meaningfully reduced pricing risk as a result.

Pricing reflects the claim's liability and damages risk without an equivalent validity-challenge exposure, generally allowing more straightforward risk-adjusted pricing against the expected recovery. The absence of a binary invalidation risk simplifies the funder's modeling relative to a comparable patent claim.

Beyond ordinary litigation risk, IP claims carry the distinct risk that the underlying right itself is challenged and narrowed or invalidated during the litigation, a risk category that does not exist for most commercial claims where the underlying legal right is not itself in dispute.

Risk is generally confined to whether the claimant can prove liability and damages against a collectable defendant, without an additional layer of risk to the underlying legal right supporting the claim.

IP litigation finance wins when a patent, trademark, or trade secret holder has a claim strong enough to withstand validity or ownership challenges and needs funders with the technical underwriting capability to properly assess that specific risk. It is especially valuable for smaller innovators facing a well-resourced, sophisticated infringer capable of mounting an aggressive validity challenge.

Commercial litigation finance wins for the broader range of business disputes where liability and damages, not the validity of an underlying intellectual property right, are the central questions driving the claim's value. This broader category encompasses the great majority of commercial claims funders evaluate in any given year.